Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Webster Centre: Archive news

On the Cover of Biochemical Journal

molecularmechanismstn

Thursday, 26 May 2016

Recent research from the laboratory of the Director, Professor Kurt Krause, has appeared on the cover of the Biochemical Journal.  This work involved Professor Krause, Sinothai Poen, a recent PhD graduate, Yoshio Nakatani, Helen K Opel-Reading, Mortiz Lassé, Renwick D J Dobson and was titled "Exploring the Structure of Glutamate Racemase from Mycobacterium tuberculosis as a Template for Anti-mycobacterial Drug Discovery".

"Peak Antibiotics"

peakantibioticsthumbnail2

Tuesday, 5 April 2016

Webster Centre steering committee members, Greg Cook and Debbie Williamson, were featured in a documentary appearing on Prime on 5 April 2016. The documentary focused on the dangers of current antibiotic resistance and the need for the development of new antibiotics for the future as well as the best way to preserve current treatment options.

Vaccine Cuts Rate of Major Disease in African Children in Half

Philip Hill thumb

Thursday, 17 March 2016

Professor Philip Hill's findings on monitoring a population of 200,000 people in The Gambia, West Africa, before and after the introduction of pneumococcal conjugate vaccine appear in the prestigious Lancet Infectious Diseases.

New tool to accelerate health research

Crystal imager tn2

Friday, 26 February 2016

A new protein crystallography tool available to Otago researchers will help accelerate research into drug and vaccine design.

Volcanic bacteria take minimalist approach to survival

Greg cook tn

Thursday, 4 February 2016

Professor Greg Cook appeared as a co-author in the Proceedings of the National Academy of Sciences describing his work on volcanic bacteria entitled "Persistence of the dominant soil phylum Acidobacteria by trace gas scavenging".

MOH tenders for 300,000 doses of H5N1 vaccine

Kurt Krause tn

Sunday, 10 January 2016

In January 2016 Professor Kurt Krause commented on New Zealand’s preparation for pandemic influenza by the Ministry of Health tendering for 300,000 doses of vaccine for H5N1, one prominent strain of bird flu. He acknowledged that it is fair to be concerned about whether the correct strain was chosen because no-one knows for sure which bird flu strain, if any, will cause widespread human infection. However the H5N1 vaccine is probably the best bet we have right now.  Another big issue was how quickly countries could get hold of enough vaccinations for an entire population during a pandemic.

OIHRN Meeting

OIHRN logo tn

Friday, 13 November 2015

OIHRN Meeting

The 8th annual OIHRN meeting was held at St Margaret's College at Dunedin on 11 - 12 November 2015.  Steering committee members, Dr Deborah Wililamson, presented on "Poultry, Potions and Public Health: infectious diseases genomics in NZ and beyond” and Professor Philip Hill presented on “The Impact of Pneumococcal Conjugate Vaccines in the Gambia, West Africa”.  The Webster Centre was pleased to serve as a sponsor for this event.

Ebola and beyond—how bugs kill us

capsules tn

Saturday, 5 September 2015

On Monday, 31 August 2015, a free Public Outreach Question It meeting "Ebola and Beyond - How Bugs Kill Us" was held in the Queenstown Memorial Centre from 12 - 1pm.  Infectious disease researchers, Dr Siouxsie Wiles, Auckland University; Professors Kurt Krause, Otago University and Nigel French, Massey University were panel members in a discussion about the growing global problem of these deadly bugs and how to maximise your chances against them.

Rheumatic Fever Workshop

hotel-overview-rendezvous-grand-hotel-auckland-1

Saturday, 21 March 2015

In conjunction with the Australasian Society of Infectious Diseases Annual Scientific Meeting, this workshop was held on Friday 20 March 2015, Rendezvous Hotel, Auckland. 

Antibiotic resistance and industry

Kurt Krause tn

Tuesday, 27 January 2015

Professor Kurt Krause responds to an opinion about industry's role in growing antibiotic resistance, in an interview with Kathryn Ryan on Radio NZ.

Huge toll from seasonal influenza

flu thumbnail

Tuesday, 25 November 2014

Professor Michael Baker discusses a new paper about the large public health impact of influenza in New Zealand.

Investigating natural immunity to TB

Ayesha Verrall thumb

Wednesday, 19 November 2014

Dr Ayesha Verrall is investigating natural immunity to TB as part of her doctoral thesis. She is interviewed by the Otago Daily Times about her work.

NZ's role in fighting Ebola

Ebola (thumbnail-size image)

Wednesday, 29 October 2014

Professor Michael Baker calls on the NZ Government to send health workers to Ebola affected areas of West Africa as part of a WHO effort.

Nuffield Scholarship awarded

Andrew Highton tn

Tuesday, 23 September 2014

Andrew Highton PhD, past winner of a Webster Centre Travel Award, has received a prestigious Nuffield Scholarship to Oxford University.

Health impacts of poor housing

Prof-Michael-Baker-tn

Monday, 15 September 2014

Professor Michael Baker, a Webster Centre for Infectious Diseases research leader, comments on the health risks of poor housing.

Distinguished Research Medal awarded

Greg cook tn

Tuesday, 5 August 2014

Professor Greg Cook received the 2014 Distinguished Research Medal for his substantial contribution to microbial research.

Renewed interest in alternative remedies

Kurt Krause tn

Saturday, 3 May 2014

Professor Kurt Krause, Director of the Webster Centre for Infectious Diseases, suggests that the post-antibiotic era may create renewed interest in alternative remedies.

Superbugs challenge antibiotics

capsules tn

Thursday, 1 May 2014

Resistance to antibiotics is no longer a prediction for the future according to the World Health Organisation (WHO), which claims it is happening now in every region of the world.

Evidence lacking for flu jab substitutes

flu jab needle going into arm thumbnail

Thursday, 3 April 2014

Professor Michael Baker, of the Webster Centre for Infectious Diseases, expresses concern about alternatives offered in place of flu vaccination.

Liley Medal presented to Professor Michael Baker

Michael Baker tn

Wednesday, 27 November 2013

The prestigious Liley Medal 2013 was presented to Professor Michael Baker in recognition of his landmark 2012 study of infectious diseases and rising inequalities in NZ.

The end of antibiotics?

Kurt Krause tn

Wednesday, 20 November 2013

Professor Kurt Krause is interviewed on the end of antibiotics and the threat of superbugs.

EU consortium investigates TB and diabetes links

Philip Hill tn

Monday, 3 December 2012

Professor Philip Hill, who has an extensive record in TB research in developing countries, will be part of a multi-disciplinary consortium exploring the link between TB and diabetes.

New Zealand's E.coli risk

Plate of food thumbnail

Monday, 12 September 2011

Following the outbreak in Europe, Infectious Diseases experts discuss New Zealand's E.coli risk, on TVNZ programme Close Up.

TB susceptibility linked to gene

Philip Hill tn

Monday, 16 August 2010

International health researcher, Professor Philip Hill,  is part of a consortium that has successfully used genome scanning to identify a gene associated with increased susceptibility to tuberculosis (TB) in African populations.

Risk of superbug to New Zealand

Kurt Krause tn

Monday, 12 April 2010

Professor Kurt Krause in interviewed on ONE News about the risk of a drug-resistant superbug travelling to New Zealand.

Health regulations tested by flu

Michael Baker tn

Monday, 4 May 2009

University of Otago Associate Professor Michael Baker says, in an Otago Daily Times report, that the swine flu outbreak is providing a major test of new international health regulations.

Using Tamiflu effectively

Kurt Krause tn

Thursday, 30 April 2009

Professor Kurt Krause answers common questions about the drug Tamiflu, and how it can be best utilised against swine flu, on TVNZ's  Breakfast programme.

Tuberculosis resources poor

Monday, 27 April 2009

Guest speaker, Dr Clifton Barry, at the Webster Centre for Infectious Diseases Symposium, expressed his concern about the lack of resources to address Tb.